With the revision adopted by Parliament, agreements between companies will no longer be automatically deemed unlawful and ...

COMMENTARY. The Zurich-based investment company will leave the SME compartment for SIX’s main segment, where it hopes to ...

ANALYSIS. Richemont is now the sole luxury sector representative among the Swiss stock market blue chips. And the name ...

The financial health of many pension institutions has become so strong that they have started redistributing surpluses to ...

The Swiss Competition Commission has concluded an investigation spanning over ten years into interest rate derivatives, ...

In a world where uncertainty has become the new normal, our small Alpine republic must nurture the values that have built its ...

COMMENTARY. Based on a motion calling for the restoration of the presumption of innocence for companies targeted by Comco, elected officials have made competition regulation even more questionable.

The biopharma network of Relief Therapeutics is crucial for marketing the neurotherapies developed by Mindmaze, according to ...

A key figure in the Swiss financial center, Serge Robin discusses his career and his vision of the sector's evolution in ...

On Thursday, the upper chamber endorsed a National Council decision instructing the executive to reverse the retroactivity of ...

After a disastrous first session on Monday, shares of the Lausanne-based company born from the merger of NeuroX and Relief ...

Geneva’s GDP growth outpaces the Swiss average due to the predominance of services, which are mostly immune to US tariffs.